Kaan SÖZMEN, Belgin ÜNAL, Sibel SAKARYA, Gönül DİNÇ, Nazan YARDIM, Bekir KESKİNKILIÇ, Gül ERGÖR

Association of Anthropometric Measurement Methods with Cardiovascular Disease Risk in Turkey

Objective: The aim of this study is to compare the predictive power of anthropometric indices for risk of developing Coronary Heart Disease (CHD) or CHD death.Methods: We used cross-sectional data from nationally representative Chronic Diseases and Risk Factors Survey conducted by the Ministry of Health in 2011. Body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR), waist to height ratio (WHtR), body adiposity index (BAI) and A Body Shape Index (ABSI) formed the anthropometric measures. For each participant risk of developing CHD or dying from CVDs were calculated based on Framingham and SCORE risk equations. Predictive ability of anthropometric measurements was assessed by receiver operating characteristic (ROC) curves.Results: Anthropometric measurements of central obesity recorded higher area under the ROC curve (AUC) values than BMI in both men and women. While ABSI had the highest AUC values for Framingham 10-year predicted risk (FRS) for CHD death (AUC = 0.613), SCORE 10-year risk for CVD death (AUC = 0.633), in women AUC for ABSI was the highest for only SCORE risk threshold (AUC = 0.705). Among women, WHtR was found to be the best indicator for estimating CHD incidence (AUC = 0.706) and death from CVD (AUC = 0.696).Conclusion: Compared to traditional anthropometric measurements such as BMI, ABSI was a better indicator for given thresholds for estimating the risk of developing CHD and CVD death in men. Among women WHtR made better predictions for FRS thresholds, however, ABSI was better for predicting 10-year risk of CVD death calculated by SCORE risk equation.Key words: Obesity, Framingham risk score, coronary heart disease

Anahtar Kelimeler:

Obezite, Framingham risk skoru, koroner kalp hastalığı

Determining a Safe Time for Oral Intake Following Pediatric Sedation

Objective: While there are suggestions for oral hydration times after general anesthesia, there is no published study with regard to sedation. The aim of this prospective study was to determine a safe time for oral intake after pediatric sedation and its association with nausea and vomiting after discharge.Methods: A total of 180 children (aged 1 month to 13 years) sedated for magnetic resonance imaging were randomly assigned into three groups. All patients fasted for 6 hours and were allowed to take clear fluids until 2 hours before sedation with thiopental (3 mg/kg). After the patients were transported to the recovery room, we allowed the patients to drink as much clear fluids as they wanted prior to discharge in group I, 1 hour after the patients met the discharge criteria for group II, and 2 hours after the patients met the discharge criteria for group III. All patients were assessed for vomiting in the recovery room until 1 hour after their first oral hydration. The parents were then telephoned the next day and questioned regarding nausea/vomiting and any unanticipated hospital admission.Results: There were no statistically significant intergroup differences with respect to age, sex, weight, or the ASA status. There was no nausea and vomiting in either the recovery or post discharge period in any group. In the telephone questionnaire, no hospital admissions were reported.Conclusion: Oral hydration just before discharge is safe, and fasting children after discharge for a period of time is unnecessary for patients sedated with thiopental.Key words: Sedation, oral intake, postoperative nausea and vomiting

Keywords:

-,

PDF

___

Obesity and overweight. Secondary obesity and overweight
[http://www.who.int/mediacentre/factsheets/fs311/en/]
Klein S, Allison DB, Heymsfield SB, et al. Waist circumference
and cardiometabolic risk: a consensus statement from Shaping America’s Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr 2007;85:1197-1202.
Stevens GA, Singh GM, Lu Y, et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr 2012;10:22.
Satman I, Omer B, Tutuncu Y et al. Twelve-year trends in the
prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013;28:169-180.
Nelson MR. Management of high blood pressure in those without overt cardiovascular disease utilizing absolute risk scores. Int J Hypertension 2011;21:235-340.
Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003.
Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better
screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 2012;13:275-286.
Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity (Silver Spring) 2011;19:1083-1089.
Krakauer NY, Krakauer JC. A new body shape index predicts
mortality hazard independently of body mass index. PLoS One. 2012;7:e39504.
Meseri R, Ucku R, Unal B. Waist:height ratio: a superior index in estimating cardiovascular risks in Turkish adults. Public Health Nutr 2014;17:2246-2252.
Türkiye Kronik Hastalıklar ve Risk Faktörleri Sıklığı Çalışması, Sağlık Bakanlığı, Ankara 2013;909
Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines
for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187.
Wilson PW, D’Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
Freedman DS, Ogden CL, Goodman AB, et al. Skinfolds and coronary heart disease risk factors are more strongly associated with BMI than with the body adiposity index. Obesity (Silver Spring) 2013;21:E64-70.
Balkau B, Deanfield JE, Després J-P, et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007;116:1942-1951.
Winter Y, Rohrmann S, Linseisen J, et al. Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke. 2008;39:3145-3151.
Taylor AE, Ebrahim S, Ben-Shlomo Y, et al. Comparison of the associations of body mass index and measures of central adiposity and fat mass with coronary heart disease, diabetes, and all-cause mortality: a study using data from 4 UK cohorts. Am J Clin Nutr 2010;91:547-556.
Lapidus L, Bengtsson C, Larsson B, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984;289:1257-1261.
Pischon T, Boeing H, Hoffmann K, et al. General and abdominal
adiposity and risk of death in Europe. N Engl J Med 2008;359:2105-2120.
Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010;23:247-269.
Can AS, Bersot TP, Gonen M et al. Anthropometric indices and
their relationship with cardiometabolic risk factors in a sample of Turkish adults. Public Health Nutr 2009;12:538-546.
Bennasar-Veny M, Lopez-Gonzalez AA, Tauler P, et al. Body Adiposity Index and Cardiovascular Health Risk Factors in Caucasians: A Comparison with the Body Mass Index and Others. PLoS ONE 2013;8:e63999.
Dhaliwal SS, Welborn TA, Goh LG, et al. Obesity as assessed
by body adiposity index and multivariable cardiovascular disease risk. PLoS One 2014;9:e94560.
Haghighatdoost F, Sarrafzadegan N, Mohammadifard N, et al. Assessing body shape index as a risk predictor for cardiovascular diseases and metabolic syndrome among Iranian adults. Nutrition 2014;30:636-644.